Antibodies That Bind Psma And Gamma-Delta T Cell Receptors

text
January 13, 2022

Inventors

Robertus Cornelis Roovers, Johannes Jelle Van Der Vliet, Lisa Anna King, Paul Willem Henri Ida Parren, Victoria Guimarais Iglesiasd, Avid Lutje Hulsik, Peter Alexander Gerardus Maria Machielsen

Assignees

  1. LAVA Therapeutics N.V.

Abstract

The present invention relates to antibodies capable of binding human PSMA and capable of binding a human Vγ9Vδ2 T cell receptor. The invention further relates to pharmaceutical compositions comprising the antibodies of the invention and to uses of the antibodies of the invention for medical treatment.

CovalX Technology Used

Epitope Mapping

Source

Contact our Scientific Team to Start the Conversation

Request A Call
Back
Categories : Patents, Epitope Mapping
text
PREVIOUS : Antibodies That Bind To Pathological Tau Species And Uses Thereof
NEXT : Group B Streptococcus Surface Protein β: Structural Characterization of a Complement Factor H–Binding Motif and Its Contribution to Immune Evasion
text